Elicio Therapeutics, Inc.
Company Snapshot: Elicio Therapeutics, Inc.
eltx | ||||
Last | Change | Volume | High | Low |
Company Overview
Client News
- Apr 25 2024 Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
- Apr 5 2024 Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting
- Mar 29 2024 Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates